CAREER:Injectable Biomimetic Scaffolds to Direct Stem Cell-Derived Cardiomyocyte Differentiation

职业:可注射仿生支架指导干细胞衍生的心肌细胞分化

基本信息

  • 批准号:
    1150854
  • 负责人:
  • 金额:
    $ 40万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-01 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

1150854/ LipkeThe PI's long-term research goal is to develop a fundamental understanding of the mechanisms by which biomimetic materials can drive electrophysiological maturation of stem cell-derived cardiomyocytes (SC-CMs). This CAREER research plan uses a novel hydrogel microsphere encapsulation system to provide pluripotent stem cells with specific cues to direct their differentiation into cardiomyocytes and assesses the functional electrophysiological properties of resulting SC-CMs at the single cell and tissue levels. Using current differentiation methods, SC-CM maturation typically does not progress beyond a prenatal phenotype and overall electrophysiological properties vary greatly. Therefore, the objective of the PI?s research plan is to test the following hypotheses: (1) biomimetic scaffolds can be used to increase the homogeneity of SC-CMs and decrease variability in electrophysiological properties both within and between differentiation batches; (2) localized release of signaling molecules, including nitric oxide, can be used to enhance SC-CM maturity; (3) electrophysiological properties of SC-CMs will depend on the differentiation environment they are provided including variations in copolymer formulation, culture time, and initial stem cell concentration; and (4) SC-CMs will enhance electrical propagation through engineered cardiac tissues by directly coupling with more mature neonatal ventricular-derived cardiomyocytes. The following educational goals are integrated with the PI's research objective: (1) maintain a 1:1 ratio of undergraduate to graduate student researchers in her laboratory; (2) engage cardiac nursing students in learning about stem cell and cardiac regeneration research so they are better prepared to educate patients; (3) incorporate cardiovascular research-related content and projects into her coursework; (4) inspire K-12 students to pursue science and engineering careers through conducting K-12 outreach (5) support women and minority retention in science and engineering through organizational activities and one-on-one mentoring.Intellectual Merit: The PI's focus on characterizing and directing SC-CM electrophysiology is unique, particularly for SC-CMs differentiated in scalable systems or encapsulated in biomaterial scaffolds, and the anticipated results will provide a valuable foundation for others in the field. Knowledge gained from these studies will be applied to the design of injectable biomaterial scaffolds and engineered cardiac tissues to improve electrophysiological integration, which is essential for cardiac regeneration. Establishing a fundamental understanding of how to uniformly progress SC-CM electrophysiological maturity and using this information to develop differentiation systems that control batch-to-batch variability is critical to reducing SC-CM's potential to cause deadly arrhythmias. In addition, obtaining sufficient numbers of homogeneous cells to form tissues is challenging. The interdisciplinary nature of this research draws on and furthers our knowledge of fundamentals in several fields including transport phenomena and thermodynamics, electrical signal processing, and developmental biology.Broader Impacts: Heart disease is the number one cause of death in the United States each year for both men and women. Improving the ability to repair damaged or diseased hearts will provide patients the opportunity for both a longer and potentially better quality of life. The results of the PI's research will provide the foundation for educational materials that will be integrated into her core undergraduate courses and upper level cell and tissue engineering course. Cardiac nursing students, who in their careers will be important health educators, will also come to the PI's lab to learn about stem cell and cardiac regeneration research. Mentoring undergraduate researchers will continue to be a priority the PI, and she will expand her efforts to engage students from underrepresented groups. To engage K-12 students in this research and foster their interest in pursuing a career in science and engineering, the PI will use existing, successful frameworks including Auburn University's Youth Experience in Science (YES) camps and Getting Under the Surface (GUTS) program.
PI的长期研究目标是发展对仿生材料驱动干细胞源性心肌细胞(SC-CMs)电生理成熟机制的基本理解。这项CAREER研究计划使用一种新型的水凝胶微球封装系统,为多能干细胞提供特定的线索,指导它们向心肌细胞分化,并在单细胞和组织水平上评估由此产生的SC-CMs的功能电生理特性。使用目前的分化方法,SC-CM成熟通常不会超出产前表型,整体电生理特性差异很大。因此,PI的目标是什么?s的研究计划是验证以下假设:(1)使用仿生支架可以增加SC-CMs的均匀性,减少分化批次内和批次之间电生理特性的差异性;(2)一氧化氮等信号分子的局部释放可促进SC-CM的成熟;(3) SC-CMs的电生理特性将取决于它们所提供的分化环境,包括共聚物配方、培养时间和初始干细胞浓度的变化;(4) SC-CMs将通过与更成熟的新生儿心室源性心肌细胞直接偶联,增强电在工程心脏组织中的传播。以下教育目标与PI的研究目标相结合:(1)在她的实验室中保持本科生与研究生1:1的比例;(2)让心脏护理专业的学生学习干细胞和心脏再生研究,以便他们更好地准备教育患者;(3)将心血管研究相关内容和项目纳入课程作业;(4)通过开展K-12外展活动,激励K-12学生追求科学和工程职业;(5)通过组织活动和一对一指导,支持女性和少数族裔留在科学和工程领域。智力优势:PI专注于表征和指导SC-CM电生理学是独一无二的,特别是在可扩展系统中分化的SC-CM或封装在生物材料支架中,预期的结果将为该领域的其他人提供有价值的基础。从这些研究中获得的知识将应用于可注射生物材料支架和工程心脏组织的设计,以改善电生理整合,这对心脏再生至关重要。建立对如何统一推进SC-CM电生理成熟的基本理解,并利用这些信息开发控制批间可变性的分化系统,对于降低SC-CM引起致命心律失常的可能性至关重要。此外,获得足够数量的同质细胞来形成组织是具有挑战性的。本研究的跨学科性质借鉴并深化了我们在几个领域的基础知识,包括传输现象和热力学,电信号处理和发育生物学。更广泛的影响:心脏病是美国每年男性和女性死亡的头号原因。提高修复受损或患病心脏的能力将为患者提供延长寿命和提高生活质量的机会。PI的研究成果将为她的核心本科课程和高级细胞与组织工程课程提供教育材料的基础。心脏护理专业的学生在他们的职业生涯中将成为重要的健康教育者,他们也将来到PI的实验室学习干细胞和心脏再生研究。指导本科生研究人员将继续是PI的优先事项,她将扩大努力,吸引来自代表性不足群体的学生。为了吸引K-12学生参与这项研究,培养他们在科学和工程领域追求职业的兴趣,PI将使用现有的成功框架,包括奥本大学的青年科学体验(YES)营地和Getting Under the Surface (GUTS)计划。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Engineered cardiac tissue microsphere production through direct differentiation of hydrogel-encapsulated human pluripotent stem cells
  • DOI:
    10.1016/j.biomaterials.2021.120818
  • 发表时间:
    2021-05-21
  • 期刊:
  • 影响因子:
    14
  • 作者:
    Finklea, Ferdous B.;Tian, Yuan;Lipke, Elizabeth A.
  • 通讯作者:
    Lipke, Elizabeth A.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elizabeth Lipke其他文献

P31-042-23 An Improved In Vitro 3T3-L1 Adipocyte Model of Inflammation and Insulin Resistance
  • DOI:
    10.1016/j.cdnut.2023.101607
  • 发表时间:
    2023-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ifeoluwa Odeniyi;Bulbul Ahmed;Benjamin Anbiah;Grace Hester;Iman Hassani;Elizabeth Lipke;Michael Greene
  • 通讯作者:
    Michael Greene
P23-001-23 Role of CXCL7 in Colon Cancer Progression
  • DOI:
    10.1016/j.cdnut.2023.100114
  • 发表时间:
    2023-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hadeel Aldhowayan;Elizabeth Lipke;Michael Greene
  • 通讯作者:
    Michael Greene

Elizabeth Lipke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elizabeth Lipke', 18)}}的其他基金

PFI-TT: An Automated Platform for Production and Distribution of Engineered Tissue Microspheres
PFI-TT:工程组织微球生产和分销的自动化平台
  • 批准号:
    2141205
  • 财政年份:
    2022
  • 资助金额:
    $ 40万
  • 项目类别:
    Standard Grant
I-Corps: Spheroidal engineered tissues for more efficient drug discovery
I-Corps:球形工程组织可提高药物发现效率
  • 批准号:
    2107931
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
    Standard Grant
Collaborative Research: RECODE: Directing and Controlling Cardiac Differentiation Through Cellular and Microenvironmental Manipulation and Application of Machine-Learning
合作研究:RECODE:通过细胞和微环境操纵以及机器学习的应用来指导和控制心脏分化
  • 批准号:
    2135059
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
    Standard Grant
IRES Track I: Process Development for Cell and Tissue Biomanufacturing
IRES Track I:细胞和组织生物制造工艺开发
  • 批准号:
    1952614
  • 财政年份:
    2020
  • 资助金额:
    $ 40万
  • 项目类别:
    Standard Grant
Data-Driven Model Development for Cost-Effective, Reliable Cardiac Tissue Manufacturing
数据驱动模型开发,实现经济高效、可靠的心脏组织制造
  • 批准号:
    1743445
  • 财政年份:
    2017
  • 资助金额:
    $ 40万
  • 项目类别:
    Standard Grant

相似海外基金

Non invasive methods to accelerate the development of injectable therapeutic depots
非侵入性方法加速注射治疗储库的开发
  • 批准号:
    EP/Z532976/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
Transforming the future use of injectable medicines outside the hospital: Increasing capacity in the NHS
改变未来医院外注射药物的使用:提高 NHS 的能力
  • 批准号:
    EP/X025470/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
SBIR Phase I: Design and Development of Minimally-Invasive Orthopedic Fracture Fixation Using Intramedullary Sleeve and Injectable, Light-Triggered Bone Cement
SBIR 第一阶段:使用髓内套管和可注射光触发骨水泥的微创骨科骨折固定的设计和开发
  • 批准号:
    2322411
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
    Standard Grant
Catheter-injectable system for local drug delivery after myocardial infarct
用于心肌梗死后局部给药的导管注射系统
  • 批准号:
    10722614
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
Injectable Hydrogels to Deliver Gene Therapy for Myocardial Infarct
可注射水凝胶为心肌梗塞提供基因治疗
  • 批准号:
    10732139
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
Surmounting substance use disorder using an ultra-long acting injectable platform.
使用超长效注射平台克服药物滥用障碍。
  • 批准号:
    10586277
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
The Injectrode- An injectable, easily removable electrode as a trial lead for baroreceptor activation therapy to treat hypertension and heart failure
Injectrode——一种可注射、易于拆卸的电极,作为压力感受器激活疗法的试验引线,以治疗高血压和心力衰竭
  • 批准号:
    10697600
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
Examining injectable buprenorphine implementation strategies in low-threshold and primary care settings
检查低阈值和初级保健环境中注射丁丙诺啡的实施策略
  • 批准号:
    10591424
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
SBIR Phase II: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts
SBIR II 期:可注射蛋白质基质,增强自体脂肪移植物的稳定性
  • 批准号:
    2304430
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
    Cooperative Agreement
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了